Found 11 matching trials
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
PHASE2Part A of this study evaluates iopofosine I 131 (CLR 131) in patients with ...
Status
Active Not Recruiting
Location
Cellectar Biosciences site
Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
PHASE1The study evaluates CLR 131 in children, adolescents, and young adults with...
Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital
Evaluation of Iopofosine I 131 vs. R-CD in WM Patients
PHASE3The goal of this clinical trial is to evaluate whether iopofosine I 131 is ...
Location
Multiple Locations
Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors
PHASE1The purpose of the study is to investigate the safety, biodistribution, rad...
CLR 131 Combined With Radiation for Head and Neck Cancer
PHASE1This is a Phase 1 study of the use of an investigational drug that selectiv...
Location
UW Cancer Center Johnson Creek
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1The primary objective of the study is to determine the safety and tolerabil...
Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned
PHASE1The purpose of this study is to determine the recommended dose of I-131-CLR...
Location
City of Hope National Medical Center
Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma
PHASE2The purpose of this study is to determine the recommended dosing of I-131-C...
Location
University of Maryland School of Medicine
Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
PHASE1The purpose of this dose finding study is to evaluate the safety and effica...
Status
Active Not Recruiting
Location
Stanford University
Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
PHASE2The primary objective of this trial is to determine the optimal dose and im...